barker.online
BY
ROBERT BARKER
|
APRIL 30, 1999 |
Who
Do You Think Those Mutual-Fund Fees Fatten?
|
New research shows some $6 billion worth last year
alone did no good for shareholders
|
Each
time you visit the supermarket, how would you like to pay extra just
to help the store with the cost of erecting a big sign out front?
With the next car you buy, how about giving the dealer a few bucks
more toward those dreadful ads on TV? Or when you get your next checkup,
surely you'd be happy to shell out a surcharge so your friendly doctor
can join a health-maintenance organization, wouldn't you?
Of course not. Yet Americans each year are spending billions to help
mutual-fund companies pay for advertising and other marketing expenses.
These range from logo-adorned coffee mugs, mouse pads, baseball caps,
and other dreck, to lunches for investment advisers and others who
can help direct money to a fund family. Just this week, yours truly
declined a fund marketer's invitation to a Major League Baseball game.
All this adds up -- big-time. The tab last year came to more than
$6 billion, Vanguard Group Senior Chairman John Bogle writes in his
new book, Common Sense on Mutual Funds (John Wiley & Sons, 468 pages,
$24.95). And that was just the amount collected in so-called 12b-1
fees. The book also points out that investors pay millions more to
see their funds become part of the large "supermarkets" run by the
likes of Charles Schwab and Fidelity Investments.
DUBIOUS THEORY.
Can this be legal? Strangely, the answer is yes. Back in 1980 -- a
time when the fund industry was hurting -- the Securities & Exchange
Commission agreed to let fund sponsors levy these fees on the dubious
theory that if fund holders helped pay for ads, more money would flow
into the funds and, as economies of scale took hold, investors' total
costs would fall. The fund providers -- see accompanying table "Fund
Fee Hall of Shame" for a list of some of the big firms charging
maximum marketing fees -- claimed that in the end, shareholders would
benefit.
|
"The
claim that 12b-1 fees do not increase [total] expenses just
does not seem to be true"
|
|
Despite
wide suspicion to the contrary, they've kept making that case. Yet
now, fresh research from a professor at the University of Pennsylvania's
Wharton School finds that 12b-1 fees have done nothing but enrich
fund companies at the expense of shareholders. "The claim that 12b-1
fees do not increase [total] expenses just does not seem to be true,"
Nicolaj Siggelkow, a Wharton assistant professor, told me this week.
To see how 12b-1 fees had affected total shareholder costs, Siggelkow
performed a statistical analysis of thousands of funds over the period
1992 to 1996. He looked at the data many different ways, controlling
for such variables as different kinds of "loads" or sales charges,
the age of each fund, and its level of customer service. None of those
mattered.
SAME RESULT.
"The costs go up, and they stay up," Siggelkow found. "Any way you
shake it, any way you slice and dice it -- using new funds, using
old funds, using funds that switch [from no 12b-1 fee to charging
a 12b-1 fee] -- that result always comes out to an almost a one-to-one
relationship: You charge 20 basis points or 30 basis points in 12b-1
fees and, lo and behold, controlling for anything else, your expense
ratio is 20 to 30 basis points higher." (A basis point is one one-hundredth
of a percentage point.)
In our free market, it's no surprise that the fund sponsors should
do everything they can to increase their profits. But the way funds
are organized under federal securities laws -- and the way the 12b-1
rule is written -- the men and women who sit on the funds' boards
of directors are obliged to look out for the fund holders' interests
first. In other words, they're supposed to ask: Is this 12b-1 fee
helping investors in the fund?
Siggelkow's research, which also found that the funds' use of so-called
"soft dollar" rebates on stock-brokerage commissions is not aiding
fund investors, hasn't yet been published and so remains untested
by potential critics from Wall Street. He is set, however, to present
his paper to some leading Wall Streeters at a conference Wharton is
holding on May 7.
I'm betting that once his findings are widely known, it will be harder
for fund directors to keep a straight face when claiming that 12b-1
fees are benefiting the investors to whom they owe a fiduciary duty.
In the meantime, you can help yourself by resolving never to buy a
fund that levies a 12b-1 fee, something you should have little trouble
doing if you just keep your eyes open. Although 6,722 of the 10,614
funds in Morningstar's database charge 12b-1 fees -- and more than
a third of them take the 1% maximum -- that still leaves 3,892 that
don't. Look to those first.
Barker
covers personal finance in his weekly column, The Barker Portfolio,
for Business Week from Melbourne Beach, Fla. And he appears every
Friday on Business Week Online
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
EDITED
BY DOUGLAS HARBRECHT |